Graphjet Technology Publishes Presentation on Investor Website
KUALA LUMPUR, Malaysia, April 02, 2024 (GLOBE NEWSWIRE) — Graphjet Technology (“Graphjet” or “the Company”), the first and only developer […]
J & J SNACK FOODS SCHEDULES FISCAL 2024 SECOND QUARTER EARNINGS CONFERENCE CALL AND WEBCAST
MOUNT LAUREL, N.J., April 02, 2024 (GLOBE NEWSWIRE) — J & J Snack Foods Corp. (NASDAQ: JJSF) announced today that […]
Microchip Technology Appoints Rich Simoncic as Chief Operating Officer
CHANDLER, Ariz., April 02, 2024 (GLOBE NEWSWIRE) — (NASDAQ: MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected […]
Locafy Reports Fiscal First Half 2024 Results
Fiscal First Half 2024 Highlighted by Ongoing Cost Reduction Initiatives Resulting in $3.6 Million Year-Over-Year Decrease in Operating Expenses Partnerships […]
OneMedNet Completes Securities Purchase Agreement, Solidifying Cash Position to Accelerate Growth
MINNEAPOLIS, April 02, 2024 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade […]
View, Inc. Reaches Agreement with Cantor Fitzgerald and RXR to Become a Private Company
Balance sheet restructuring designed to strengthen View’s financial position Approvals received from key stakeholders across capital structure MILPITAS, Calif., April […]
Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference
SAN CARLOS, Calif., April 02, 2024 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity […]
Robinhood Markets, Inc. to Announce First Quarter 2024 Results on May 8, 2024
MENLO PARK, Calif., April 02, 2024 (GLOBE NEWSWIRE) — Today, Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) announced that it will […]
Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue
SEATTLE, April 02, 2024 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to […]
Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024
NEW YORK and SAN DIEGO, April 02, 2024 (GLOBE NEWSWIRE) — Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company […]
